Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Global Net Lease, Inc. declared quarterly cash dividends for its Series A, B, D, and E preferred stock. All dividends are payable on October 15, 2026, to stockholders of record as of the close of business on October 2, 2026. The dividend amounts range from $0.4296875 to $0.46875 per share depending on the specific series of preferred stock.
Peter Luo, CEO, bought 20,290 shares of Adagene Inc. at $3.15 a share, worth $64K in total on Sep 16, 2026. Shares held after the trade: 88,535 (+29.7%).
Baozun Chief Strategy Officer Junhua Wu Buys $37.9K of Stock
Junhua Wu, Chief Strategy Officer, bought 13,900 shares of Baozun Inc. at $2.73 a share, worth $37.9K in total on Sep 15, 2026. Shares held after the trade: 281,170 (+5.2%).
United Microelectronics CFO & SVP Chitung Liu Sells $229M of Stock
Chitung Liu, CFO & SVP, sold 1,600,000 shares of United Microelectronics Corp at $142.33 to $145.00 a share (average $143.00) in 2 transactions, worth $229M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 2,639,757 (-13.2%).
YETI Holdings hosted its 2026 Investor Day in Austin, Texas, to unveil its long-term growth strategy and financial framework through fiscal 2030. The company outlined four strategic priorities, including reaching $1 billion in international sales and generating over $1.2 billion in cumulative free cash flow over the next five years.
“The next chapter for YETI is about building a larger, more global and more durable company, supported by expanding product platforms, improving profitability and strong free cash flow generation. As we enter our next decade, we are focused on four priorities: creating the next billion dollars of sales, building our next billion-dollar product platform, generating a billion dollars of sales outside the United States and delivering more than a billion dollars of cumulative free cash flow.”
Matt Reintjes, Chair of the Board, President and Chief Executive Officer
NeOnc Technologies executives, including CEO Amir Heshmatpour and CMO Dr. Thomas Chen, have purchased approximately $629,000 worth of company stock in the open market following positive Phase 2a clinical results. CEO Heshmatpour specifically purchased 35,000 shares on September 15, 2026, bringing his total personal investment in the company to over $1.5 million in the past year.
Cenntro Inc. closed a private placement of 15,120,000 shares of common stock at a price of $3.773 per share, raising approximately $57.05 million in gross proceeds. The company amended an earlier agreement to increase the offering size and intends to use the funds for working capital and general corporate purposes.
BCB Bancorp, Inc. priced an underwritten public offering of 11,000,000 shares of common stock at $7.75 per share, generating gross proceeds of $85.25 million. The company intends to use the net proceeds for general corporate purposes, including maintaining liquidity, supporting bank capital, and reducing debt. Piper Sandler & Co. is acting as the sole book-running manager for the offering.
Salesforce hosted its 2026 Investor Day at Dreamforce, filing a formal presentation deck outlining its long-term strategic and financial framework. The company introduced a FY30 revenue target of $63 billion or more and discussed its 'Agentic Enterprise' strategy focused on AI software and Agentforce. Management also highlighted capital allocation plans including a forecast of 190% free cash flow return and a 14% expected share count reduction by FY27.
D-Wave Quantum announced it will host Qubits Asia 2026: Quantum Realized, a full-day quantum computing user conference on October 28, 2026, in Seoul. The event will feature presentations from D-Wave executives and customers like NTT DOCOMO and LG CNS regarding real-world production applications and advancements in annealing and gate-model technologies.
Beacon Topco, Inc. launched a cash tender offer to repurchase up to $15 million of its common stock at a price of $6.6609 per share. The offer follows the completion of a transaction where the company acquired Barinthus Biotherapeutics plc via a court-sanctioned scheme of arrangement.
Duos Technologies Group entered into a formal employment agreement with CEO F. Douglas Recker, effective April 1, 2026. The agreement includes a base salary of $650,000, a target performance bonus of 125% of base salary, and the grant of up to 880,000 restricted shares of common stock subject to time and performance-based vesting through 2028.
Mechanics Bancorp Divestiture to Bank of America for $417M
Mechanics Bancorp's subsidiary, Mechanics Bank, completed the sale of approximately $417 million in performing indirect auto loans to Bank of America's trading desk. The transaction involves the substantial majority of the company's runoff auto loan portfolio and was priced near book value. The divestiture is intended to optimize the balance sheet, reduce risk, and improve liquidity.
Beta Bionics, Inc. priced a public offering of 7,652,175 shares of common stock and pre-funded warrants for gross proceeds of approximately $150.0 million. The offering was priced at $17.25 per share, and the company granted underwriters a 30-day option to purchase up to an additional 1,304,348 shares. Proceeds are intended for general corporate purposes, including the commercialization of its Mint product and manufacturing facility expansion.
Value
$150M
Counterparty
J.P. Morgan Securities LLC, Piper Sandler & Co., Wells Fargo Securities, LLC and Leerink Partners LLC
News Corp provided a daily update on its $1 billion stock repurchase program as required by the Australian Securities Exchange (ASX). The program authorizes the company to repurchase outstanding shares of both Class A and Class B common stock from time to time in the open market. The filing includes specific daily transaction notifications for Class A common stock as part of this ongoing capital return initiative.
Brand Engagement Network M&A Deal with Cataneo GmbH
Brand Engagement Network Inc. filed audited consolidated financial statements for Cataneo GmbH for the years ended December 31, 2025 and 2024. This filing provides required historical financial data following a previously announced acquisition or merger update involving Cataneo GmbH. The exhibit includes a full set of GAAP financial statements including balance sheets, operations, and cash flows.
Nordicus Partners $600K Debt Financing with Keystone Capital Partners LLC
Nordicus Partners Corporation issued a $600,000 Convertible Grid Promissory Note to Keystone Capital Partners LLC in exchange for $500,000 in cash. The note bears 5% interest and matures on June 10, 2027, with conversion rights triggered only upon an event of default after the maturity date. As consideration for the funding, the company also agreed to issue 250,000 commitment shares of common stock to the lender.
Sonoma Pharmaceuticals held its annual meeting of stockholders on September 16, 2026, where shareholders elected Jerry McLaughlin as a Class III director. Stockholders also approved executive compensation on an advisory basis and ratified the appointment of Frazier & Deeter, LLC as the company's independent accounting firm for the fiscal year ending March 31, 2027.
Impact Biomedical Inc. announced the filing of a Form F-4 registration statement by Zoar Limited in connection with their previously announced business combination. The filing represents a major milestone toward closing the merger, which will result in a combined pharmaceutical company focused on active pharmaceutical ingredients and special therapeutic treatments. The transaction remains subject to SEC effectiveness, stockholder approval, and NYSE American listing approval.
Heartland Express declared a regular quarterly cash dividend of $0.02 per share, payable on October 7, 2026, to shareholders of record as of September 25, 2026. This represents the company's 93rd consecutive quarterly dividend, with an estimated total payout of $1.5 million.
Boston Omaha Insider Brendan Joseph Keating Sells $1.37M of Stock
Brendan Joseph Keating sold 100,994 shares of Boston Omaha Corp at $13.56 a share, worth $1.37M in total on Sep 15, 2026. Shares held after the trade: 0 (-100.0%).
Landmark Bancorp Insider Jim Lewis Sells $13.2K of Stock
Jim Lewis sold 400 shares of Landmark Bancorp Inc at $32.92 a share, worth $13.2K in total on Sep 15, 2026. Shares held after the trade: 152,796 (-0.3%).
Terawulf Insider Michael C. Bucella Buys $90K of Stock
Michael C. Bucella bought 6,085 shares of Terawulf Inc. at $14.79 a share, worth $90K in total on Sep 15, 2026. Shares held after the trade: 350,789 (+1.8%).
Natera Executive Chairman Matthew Rabinowitz Sells $34.8M of Stock
Matthew Rabinowitz, Executive Chairman, sold 102,000 shares of Natera, Inc. at $328.09 to $351.25 a share (average $341.15) in 29 transactions, worth $34.8M in total between Sep 14, 2026 and Sep 15, 2026. Shares held after the trade: 2,187,658 (-0.1%).
Ralliant President and CEO Tamara S. Newcombe Sells $845K of Stock
Tamara S. Newcombe, President and CEO, sold 12,936 shares of Ralliant Corp at $65.30 a share, worth $845K in total on Sep 14, 2026. Shares held after the trade: 246,897 (-5.0%).
Mach Natural Resources Insider Tom L. Ward Buys $2M of Stock
Tom L. Ward bought 172,413 shares of Mach Natural Resources LP at $11.60 a share, worth $2M in total on Sep 14, 2026. Shares held after the trade: 13,467,452 (+1.3%).
Puma Biotechnology Insider Troy Edward Wilson Sells $45.5K of Stock
Troy Edward Wilson sold 5,000 shares of Puma Biotechnology, Inc. at $9.10 a share, worth $45.5K in total on Sep 14, 2026. Shares held after the trade: 54,750 (-8.4%).
Fluent 10% Owner Global Value Investment Corp. Buys $41.8K of Stock
Global Value Investment Corp., 10% Owner, bought 12,376 shares of Fluent, Inc. at $3.38 a share, worth $41.8K in total on Sep 14, 2026. Shares held after the trade: 3,229,627 (+0.4%).
James Geygan, Director, bought 12,376 shares of Fluent, Inc. at $3.38 a share, worth $41.8K in total on Sep 14, 2026. Shares held after the trade: 3,137,960 (+0.4%).
Puma Biotechnology Insider Alessandra Cesano Sells $567K of Stock
Alessandra Cesano sold 62,150 shares of Puma Biotechnology, Inc. at $9.12 a share, worth $567K in total on Sep 14, 2026. Shares held after the trade: 56,700 (-52.3%).